CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

Lintuzumab (SGN-33) - Phase 2 | SGEN Pipeline | CatalystAlert